In addition, selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1.5 million shares of common stock to cover over-allotments, if any.
InvenSense will not receive any proceeds from any sale of shares by the selling stockholders.
Goldman, Sachs & Co. and Morgan Stanley & Co. LLC are acting as joint book-running managers for the offering. Oppenheimer & Co. Inc., Piper Jaffray & Co., Robert W. Baird & Co. Incorporated and ThinkEquity LLC are acting as co-managers for the offering. InvenSense common stock will trade on the New York Stock Exchange under the symbol "INVN." The offering of these securities will be made only by means of a prospectus, copies of which may be obtained from Goldman, Sachs & Co., via telephone: (866) 471-2526; facsimile: (212) 902-9316; email: [email protected]; or standard mail at Goldman, Sachs & Co., Attn: Prospectus Department, 200 West Street, New York, NY 10282; and from Morgan Stanley & Co. LLC, via telephone: (866) 718-1649; email: [email protected]; or standard mail at Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.
Investor inquiries may be sent to [email protected].
InvenSense makes motion processing chips based on MEMS technology. Learn more at http://invensense.com/index.html